Catalyst Wire Dossier Catalyst Wire Dossier

AVTX-801

D-galactose
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AVTX-801, covering 2025-06-29 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Efficacy and Safety of D-galactose in PGM1-CDG (AVTX-801) [Phase 2]

See pricing